Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-181

https://www.********.au/2024/03/26/mesoblast-share-price-rockets-36-on-breaking-fda-news/

Craply Fools screen scrape programs eventually picked up the afternoon rally.

The usual 'friends of MSB' trying to urinate on a 45% rally announcement on Hot Copper of course.

This was an update late in the US day, that Silviu and co. clearly scrambled to clarify, undoubtedly via lawyers (hence the relatively non-committal language) and a pause in trading. We will no doubt get further clarification in coming days, hopefully in more formal settings - SI has arguably been guilty of flapping his gums too much on MSB's prospects in less formal settings and will have learnt his lesson.